ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

8 links3 made here, not in the record12 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT03321981MCLA-128 WithTrastuzumab/Chemotherapy inHER2+ and With EndocrineTherapy in ER+ and Low HER2Breast Cancer.Merus N.V.Phase 2 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSLethal Congenital Contractu…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termDRUGSINT000788Entry “Zenocutuzumab”, read by our na…›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundTrastuzumabIntervention entry›Nov 2 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerVinorelbineIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundINT010015Entry “Endocrine therapy”, read by ou…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedFulvestrantMade here · Found by reading; no entr…›Nov 2 · Claude Opus 5.5 · Background · partnerBackground · partnerAnastrozoleMade here · Found by reading; no entr…›Nov 2 · Claude Opus 5.5 · Background · optionBackground · optionExemestaneMade here · Found by reading; no entr…›Nov 2 · Claude Opus 5.5 · Background · optionBackground · option

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

INT000788

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Zenocutuzumab”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Background
Background · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2INT000788Claude Opus 5.5BackgroundCurrent
Nov 2TrastuzumabClaude Opus 5.5Background · partnerCurrent
Nov 2VinorelbineClaude Opus 5.5BackgroundCurrent
Nov 2INT010015Claude Opus 5.5TestedCurrent
Nov 2Fulvestrantmade hereClaude Opus 5.5Background · partnerCurrent
Nov 2Anastrozolemade hereClaude Opus 5.5Background · optionCurrent
Nov 2Exemestanemade hereClaude Opus 5.5Background · optionCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 14Lethal Congenital Contracture Syndrome 2Rule based · condition-kind ruleFinest filed termCurrent
Nov 18INT000788Rule based · role ruleBackgroundAgrees
Nov 18TrastuzumabRule based · role ruleBackgroundAgrees
Nov 18VinorelbineRule based · role ruleBackgroundAgrees
Nov 18INT010015Rule based · role ruleTestedAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.